Replies to post #75423 on Biotech Values

[DewDiligence]

IDIX IDX899: any guesstimate on when P2 results?

Nope—GSK is running the show now on IDX899 and they alone control the disclosures.

Will IDIX be @$3/share if the head to head results vs Sustiva are favorable?

I presume your question is rhetorical. I think there’s a good chance IDIX won’t be an independent company by then.